Graphene can be used to detect cancer cells at very early stages of the disease, which plays a crucial role in improving treatment success rates and extending patients’ survival time. Thanks to its extremely high sensitivity and unique electrical and chemical properties, graphene-based sensors are able to identify very subtle changes in the biological environment, such as the presence of cancer-related biomarkers. This allows for more accurate diagnoses and enables detection much earlier than conventional methods.
Beyond detection, graphene also shows great potential in controlling and inhibiting the growth of cancer cells. It can interfere with the formation and development of tumors, thereby disrupting the growth and spread of cancer cells within the body. Through this mechanism, graphene may help slow the progression of the disease and enhance the effectiveness of other treatment methods.
In addition, graphene can stimulate autophagy, an important biological process in which cells break down and recycle their internal components. When this process is appropriately activated in cancer cells, it can lead to their destruction. The combination of early detection, tumor growth inhibition, and the promotion of autophagy makes graphene a highly promising material in both cancer diagnosis and treatment, opening up new directions for modern medicine in the future.
